Three Dimensional Navigation IntraCardiac Guidance Kit for Atrial Septal Puncture
A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of a Three Dimensional Navigation Intracardiac Guidance Kit for Atrial Septal Puncture
1 other identifier
interventional
136
1 country
1
Brief Summary
This study aims to evaluate the safety and efficacy of a three-dimensional navigation intracardiac guidance kit to perform atrial septal puncture in patients requiring catheter ablation, which will be compared with procedures using traditional kit for atrial septal puncture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable atrial-fibrillation
Started Apr 2023
Shorter than P25 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 24, 2023
CompletedFirst Submitted
Initial submission to the registry
November 19, 2023
CompletedFirst Posted
Study publicly available on registry
January 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedJanuary 3, 2024
December 1, 2023
1.1 years
November 19, 2023
January 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Success rate of atrial septal puncture
Successful atrial septal puncture is defined as the right and left interatrial pathways are established and the ablation catheter can enter the left atrium smoothly for subsequent ablation operations.
one day
X-Ray exposure time
X-ray exposure time from the successful femoral vein puncture to the entry of the external sheath into the left atrium (ending with heparin saline flushing of the sheath).
one day
Secondary Outcomes (4)
First puncture success rate of atrial septum
one day
Atrial septal puncture duration
one day
Total operation time
one day
Performance evaluation of a three-dimensional positioning intracardiac guidance kit
one day
Other Outcomes (3)
(Incidence (%) and frequency (number of events) of (serious) adverse events
one day
Incidence (%) and frequency (number of events) of device-related (serious) adverse events
one day
Incidence of device defects and number of events that occurred
one day
Study Arms (2)
Three-Dimensional Navigation Atrial Septal Puncture
EXPERIMENTALAtrial septal puncture will be performed using a three-dimensional navigation intracardiac guidance kit
Conventional Atrial Septal Puncture
ACTIVE COMPARATORAtrial septal puncture will be performed using trational atrial septal puncture kit using traditional method.
Interventions
Atrial septal puncture will be performed using a three-dimensional navigation intracardiac guidance kit
Atrial septal puncture will be performed using traditioanl two-dimensional atrial septal puncture kit using traditional method.
Eligibility Criteria
You may qualify if:
- Diagnosed with atrial fibrillation.
- Requiring catheter ablation therapy.
- Voluntarily sign the informed consent.
You may not qualify if:
- Previous atrial septal puncture.
- Blood clots in the left atrium or left atrial appendage
- Left atrial mucinous tumor.
- Atrial septal defect, including previous surgical correction or interventional occlusion.
- Acute or severe systemic infection.
- Cardiac function (NYHA classification) Ⅲ-Ⅳ.
- Contraindications to anticoagulation.
- Left ventricular ejection fraction \<35%.
- Patients with untreated or uncontrolled hyperthyroidism or hypothyroidism.
- Patients with malignancy with expected survival of less than 1 year.
- Myocardial infarction or any cardiac intervention or open procedure within the last 3 months
- Stroke and other cerebrovascular disease or thromboembolic disease within the last 3 months.
- Participated in clinical trials of other drugs or devices in the past 3 months.
- Any other condition that the investigator deems inappropriate for participation in this trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tongji Hospitallead
- Wuhan Greenrhythm Medical Technology Co., LTDcollaborator
Study Sites (1)
Tongji Hospital
Wuhan, Hubei, 430030, China
Related Publications (13)
Yu R, Liu N, Lu J, Zhao X, Hu Y, Zhang J, Xu F, Tang R, Bai R, Akar JG, Dong J, Ma C. 3-Dimensional Transseptal Puncture Based on Electrographic Characteristics of Fossa Ovalis: A Fluoroscopy-Free and Echocardiography-Free Method. JACC Cardiovasc Interv. 2020 May 25;13(10):1223-1232. doi: 10.1016/j.jcin.2020.03.015.
PMID: 32438994BACKGROUNDGraham AJ, Honarbakhsh S, O'Brien B, Schilling RJ. A Simplified Trans-Septal Puncture Technique using a Needle Free Approach for Cryoablation of Atrial Fibrillation. J Atr Fibrillation. 2017 Aug 31;10(2):1628. doi: 10.4022/jafib.1628. eCollection 2017 Aug-Sep.
PMID: 29250235BACKGROUNDHang F, Cheng L, Liang Z, Dong R, Wang X, Wang Z, Wang Z, Wu Y. Study on the Curative Effect and Safety of Radiofrequency Catheter Ablation of Paroxysmal Atrial Fibrillation via Zero-Fluoroscopy Transseptal Puncture under the Dual Guidance of Electroanatomical Mapping and Intracardiac Echocardiography. Cardiol Res Pract. 2021 May 24;2021:5561574. doi: 10.1155/2021/5561574. eCollection 2021.
PMID: 34123417BACKGROUNDFromentin S, Sarrazin JF, Champagne J, Nault I, Philippon F, Molin F, Blier L, O'Hara G. Prospective comparison between conventional transseptal puncture and transseptal needle puncture with radiofrequency energy. J Interv Card Electrophysiol. 2011 Sep;31(3):237-42. doi: 10.1007/s10840-011-9564-2. Epub 2011 Apr 19.
PMID: 21503731BACKGROUNDKnecht S, Jais P, Nault I, Wright M, Matsuo S, Madaffari A, Lellouche N, O'Neill MD, Derval N, Deplagne A, Bordachar P, Sacher F, Hocini M, Clementy J, Haissaguerre M. Radiofrequency puncture of the fossa ovalis for resistant transseptal access. Circ Arrhythm Electrophysiol. 2008 Aug;1(3):169-74. doi: 10.1161/CIRCEP.108.788000. Epub 2008 Jun 23.
PMID: 19808411BACKGROUNDSawhney V, Breitenstein A, Watts T, Garcia J, Finlay M, Lowe M, Hunter R, Earley MJ, Schilling RJ, Sporton S, Dhinoja M. A novel technique for performing transseptal puncture guided by a non-fluoroscopic 3D mapping system. Pacing Clin Electrophysiol. 2019 Jan;42(1):4-12. doi: 10.1111/pace.13541. Epub 2018 Nov 28.
PMID: 30397922BACKGROUNDKoektuerk B, Yorgun H, Koektuerk O, Turan CH, Gorr E, Horlitz M, Turan RG. Rotational Angiography Based Three-Dimensional Left Atrial Reconstruction: A New Approach for Transseptal Puncture. Cardiovasc Ther. 2016 Feb;34(1):49-56. doi: 10.1111/1755-5922.12167.
PMID: 26607305BACKGROUNDManolis AS. Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature. Curr Cardiol Rev. 2017;13(4):305-318. doi: 10.2174/1573403X13666170927122036.
PMID: 28969539BACKGROUNDRodriguez-Manero M, Martinez-Sande JL, Fandino R, Garcia-Seara J, Chierchia GB, Fernandez-Lopez XA, Osorio I, de Alegria AM, Souto-Bayarri M, Brugada P, Gonzalez-Juanatey JR. Fluoroscopic integration of the cardiac computed tomography as a guide for transseptal puncture during atrial fibrillation ablation: A feasibility study. Int J Cardiol. 2015 Apr 1;184:274-275. doi: 10.1016/j.ijcard.2015.02.035. Epub 2015 Feb 24. No abstract available.
PMID: 25731834BACKGROUNDLi C, Zhang J, Li S, Sang C, Liu N, Du X, Dong J, Ma C. A novel and easy approach to difficult transseptal puncture during atrial fibrillation ablation. J Interv Card Electrophysiol. 2021 Nov;62(2):269-276. doi: 10.1007/s10840-020-00891-y. Epub 2020 Oct 9.
PMID: 33034794BACKGROUNDROSS J Jr, BRAUNWALD E, MORROW AG. Transseptal left atrial puncture; new technique for the measurement of left atrial pressure in man. Am J Cardiol. 1959 May;3(5):653-5. doi: 10.1016/0002-9149(59)90347-9. No abstract available.
PMID: 13649591BACKGROUNDVlastra W, Delewi R, Sjauw KD, Beijk MA, Claessen BE, Streekstra GJ, Bekker RJ, van Hattum JC, Wykrzykowska JJ, Vis MM, Koch KT, de Winter RJ, Piek JJ, Henriques JPS. Efficacy of the RADPAD Protection Drape in Reducing Operators' Radiation Exposure in the Catheterization Laboratory: A Sham-Controlled Randomized Trial. Circ Cardiovasc Interv. 2017 Nov;10(11):e006058. doi: 10.1161/CIRCINTERVENTIONS.117.006058.
PMID: 29089313BACKGROUNDSalghetti F, Sieira J, Chierchia GB, Curnis A, de Asmundis C. Recognizing and reacting to complications of trans-septal puncture. Expert Rev Cardiovasc Ther. 2017 Dec;15(12):905-912. doi: 10.1080/14779072.2017.1408411. Epub 2017 Nov 30.
PMID: 29161923BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yan Wang, PhD
Tongji Hospital Wuhan, Hubei China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 19, 2023
First Posted
January 3, 2024
Study Start
April 24, 2023
Primary Completion
June 1, 2024
Study Completion
September 1, 2024
Last Updated
January 3, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share